The effect of psychotherapy in improving physical and psychiatric symptoms in patients with functional dyspepsia

Mahbobeh Faramarzi, Parviz Azadfallah, Howard E Book, Kazem Rasolzadeh Tabatabai, Hassan Taherim, Mehrdad Kashifard, Mahbobeh Faramarzi, Parviz Azadfallah, Howard E Book, Kazem Rasolzadeh Tabatabai, Hassan Taherim, Mehrdad Kashifard

Abstract

Objective: Functional Dyspepsia (FD) is a common symptom of upper gastrointestinal discomfort. Few data are available on the role of psychotherapy in the treatment of dyspeptic syndromes. This study assesses whether brief core conflictual relationship theme (CCRT) psychoanalytic psychotherapy improves gastrointestinal and psychiatric symptoms in patients with functional dyspepsia.

Methods: A randomized, controlled trial was planned in two educational hospitals in city of Babol. Forty-nine patients with FD were randomly assigned to receive standard medication treatment with CCRT psychotherapy (24 participants) or standard medication treatment alone (25 participants). The participants completed the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) and Symptom Checklist-90-Revised (SCL-90-R) questionnaires before the trial, after the treatment and at 1 and 12-month follow-ups. The mixed-effects (regression) model was used to analyze the data.

Results: The results showed that CCRT psychotherapy improved all of the FD symptoms (heartburn/regurgitation, nausea/vomiting, fullness, bloating, upper abdominal pain, and lower abdominal pain) and many of the psychiatric symptoms (depression, anxiety, somatization, interpersonal sensitivity and paranoid ideation) after the treatment and at 1-month and 12-month follow-ups.

Conclusion: Brief CCRT psychoanalytic psychotherapy can serve as an effective intervention for promoting gastrointestinal and psychiatric symptoms in patients with functional dyspepsia.

Keywords: Core Conflictual Relationship Theme; Functional dyspepsia; Psychiatric Symptoms.

References

    1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders 1999; 45: 37–42.
    1. Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. The Am J Gastroenterol 2004; 99, 2210–2216.
    1. Zagari RM, Law G, Fucci L, Eusebi L, Forman D, Bazzolo F. Epidiemiology of functional dyspepsia in Italian general population: Aendoscopic study. Gastroenterol 2010; 138, 1302–1311.
    1. Brook RA, Kleinman NL, Seon Chough R, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol 2010; 8: 498–503.
    1. Holtmann G, Gapasin J. Failed therapy and directions for the future in dyspepsia. Dig Dis 2008; 26: 218–24.
    1. Van Kerkhoven LAS, Laheij RJF, Aparicio N, De Boer WA, Van den Hazel, STan C, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol, 2008; 6: 746–752.
    1. Allescher HD. Functional dyspepsia-A multicausal disease and its therapy. Phytomedicine 2006; 13: 2–11.
    1. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology, 2006; 130: 1447–1458.
    1. Van Oudenhove L, Demyttenere K, Tack J, Aziz Q. Center nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18: 663–680.
    1. Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Demyttenaere K, et al. Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med 2007; 69: 455–463.
    1. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression:a meta-analytic review. Psychosom Med 2003; 65: 528–533.
    1. Haug T.T. Cognitive therapy in functional dyspepsia. International Congress Series 2002; 1241: 127–130.
    1. Hamilton J, Guthrie E, Creed F, Thompson B, Bennet R, Moriatry K, et al. Randomized controlled trial of psychotherapy in patients with functional dyspepsia. Gastroenterology 2000; 119: 661–669.
    1. Porcelli P, Taylor GJ, Bagby RM, De Carne M. Alexithymia and functional gastrointestinal disorders. Psychother Psychosom 1999; 68: 263–269.
    1. Vanheul S, Vandenbergen J, Verhaeghe P, Desmet M. Interpersonal problems in alexithymia: A study in three primary care groups. Psychol Psychother 2010; 83: 351–362.
    1. Hyphantis T, Gutherie E, Tomenson B, Francis C. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome. Pain 2009; 145: 196–203.
    1. Faramarzi M, Azadfallah P, Book HE, Rasolzadeh Tabatabai K, Tahari H, Shokri Shirvany J. A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia. Asian Journal of Psychiatry 2013; 6: 228–234.
    1. Tack J, Fried M, Houghton L, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome; a European perspective. Aliment Pharmacol Ther J 2006; 24: 183–205.
    1. Luborsky L. Principles of psychoanalytic psychotherapy: A manual for supportive/expressive treatment. New York: Basic Books; 1984.
    1. Book HE. How to practice brief psychodynamic psychotherapy: The Core Conflictual Relationship Theme Method. Washington, DC: American Psychological Association; 1998.
    1. Fuci AS, Braunwald E, Kasper D, Hauser SI, Lougo DI, Jamesson JL, Loscalzo J. Harrison’s principals of internal medicine ( 17nd ed., PP. 946–949). New York, NY: McGraw-Hill Medical; 2008.
    1. Halder SLS, Tally NJ. Functional dyspepsia: A new Rome III paradigm Current Treamentt Options in Gastroentrology, 2007; 10, 259–272.
    1. Book HE.How to practice brief psychodynamic psychotherapy: The Core Conflictual Relationship Theme Method. 4nd ed.Washington DC: American Psychological Association; 2007.
    1. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, Loge de la C, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal disorders. Quality of Life Research 2004; 13: 1731–1749.
    1. Brophy CJ, Norvell NK, Kiluk DJ. An examination of the factor structure and convergent and discriminant validity of the SCL-90-R in an outpatient clinic population. J Pers Assess 1988; 52: 334–340.
    1. Modabernia MJ, Shojaie Tehranie H, falahi M. [Normalization SCL-90-R Inventory in Guilan High-school(Persian)]. Journal of Guilan University of medical Sciences 2011; 75: 58–65.
    1. Gueorguieva R, Krystal JH. Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Archives of General Psychiatry, 2004; 61: 310–317.
    1. Cheng C, Yang FC, Jun S, Hutton JM. Flexible coping psychotherapy for functional dyspeptic patients: a randomized, controlled trial. Psychosom Med 2007; 69: 81–89.
    1. Haag S, senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, et al. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther 2007; 25: 973–986.
    1. Poitras MR, Verrier P, So C, Paquet S, Bouin M, Poitras P.Group counseling psychotherapy for patients with functional gastrointestinal disorders. Dig Dis Sci 2002; 47: 1297–1307.
    1. Hobson R.F. Forms of feeling. London: Tavistock; 1987.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi